Cargando…

Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963]

Detalles Bibliográficos
Autores principales: Wong, Matthew K., Liu, Jun T., Budylowksi, Patrick, Yue, Feng Yun, Li, Zhijie, Rini, James M., Carlyle, James R., Zia, Amin, Ostrowski, Mario, Martin, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155827/
https://www.ncbi.nlm.nih.gov/pubmed/37147236
http://dx.doi.org/10.1016/j.clim.2023.109246
_version_ 1785036409835356160
author Wong, Matthew K.
Liu, Jun T.
Budylowksi, Patrick
Yue, Feng Yun
Li, Zhijie
Rini, James M.
Carlyle, James R.
Zia, Amin
Ostrowski, Mario
Martin, Alberto
author_facet Wong, Matthew K.
Liu, Jun T.
Budylowksi, Patrick
Yue, Feng Yun
Li, Zhijie
Rini, James M.
Carlyle, James R.
Zia, Amin
Ostrowski, Mario
Martin, Alberto
author_sort Wong, Matthew K.
collection PubMed
description
format Online
Article
Text
id pubmed-10155827
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-101558272023-05-04 Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] Wong, Matthew K. Liu, Jun T. Budylowksi, Patrick Yue, Feng Yun Li, Zhijie Rini, James M. Carlyle, James R. Zia, Amin Ostrowski, Mario Martin, Alberto Clin Immunol Corrigendum Published by Elsevier Inc. 2023-06 2023-05-03 /pmc/articles/PMC10155827/ /pubmed/37147236 http://dx.doi.org/10.1016/j.clim.2023.109246 Text en © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Wong, Matthew K.
Liu, Jun T.
Budylowksi, Patrick
Yue, Feng Yun
Li, Zhijie
Rini, James M.
Carlyle, James R.
Zia, Amin
Ostrowski, Mario
Martin, Alberto
Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963]
title Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963]
title_full Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963]
title_fullStr Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963]
title_full_unstemmed Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963]
title_short Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963]
title_sort corrigendum to “convergent cdr3 homology amongst spike-specific antibody responses in convalescent covid-19 subjects receiving the bnt162b2 vaccine” [clinical immunology 237 (2022) 108963]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155827/
https://www.ncbi.nlm.nih.gov/pubmed/37147236
http://dx.doi.org/10.1016/j.clim.2023.109246
work_keys_str_mv AT wongmatthewk corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963
AT liujunt corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963
AT budylowksipatrick corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963
AT yuefengyun corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963
AT lizhijie corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963
AT rinijamesm corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963
AT carlylejamesr corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963
AT ziaamin corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963
AT ostrowskimario corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963
AT martinalberto corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963